HealthSkin CareSunscreenUSA
New Sunscreen Ingredient Bemotrizinol Approved by FDA
Bemotrizinol offers broad spectrum protection against UVA and UVB rays
Executive Summary
The FDA has approved bemotrizinol, a new sunscreen ingredient that offers broad spectrum protection against UVA and UVB rays. Bemotrizinol has been widely used in European and Asian sunscreens for decades and has a well-documented safety profile. This new ingredient is expected to lead to better sunscreens sold in the US and could also lead to sunscreens that look better on the skin.
Key Takeaways
- ✓Bemotrizinol offers broad spectrum protection against UVA and UVB rays
- ✓Bemotrizinol is photo stable, meaning its protection does not break down rapidly when exposed to sunlight
- ✓Bemotrizinol has a well-documented safety profile, with over 20 years of data to support its safety
- ✓Bemotrizinol is non-irritating and minimally absorbed into the skin, making it a good option for people with sensitive skin
- ✓The approval of bemotrizinol could lead to better sunscreens being available to consumers, which could help to reduce the incidence of skin cancer.
#DSM-Firmenich#Parsol Shield#FDA#Sunscreen Ingredients#Skin Protection#UVA Protection#UVB Protection
